Grantham, Mayo, Van Otterloo & Co (GMO)
CMTA

Grantham, Mayo, Van Otterloo & Co (GMO)’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-259,067
Closed -$6.76M – 815
2019
Q1 		$6.76M Buy
+259,067
New +$4.84M 0.05% 223

Grantham, Mayo, Van Otterloo & Co (GMO)'s CMTA Position: Q2 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 259,067 shares — an estimated $6.76M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $6.76M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 259,067 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $6.76M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Clementia Pharmaceuticals Inc. position peaked at $6.76M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2019, filed 13 Aug 2019.